Effect of Pulsed Magnetic Therapy Versus Phonophoresis in Discogenic Lumbar Radiculopathy Patients
Launched by CAIRO UNIVERSITY · Feb 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two treatments for patients suffering from a condition called lumbar radiculopathy, which is pain that radiates from the lower back down into the legs due to issues with the spinal discs. The two treatments being studied are pulsed magnetic therapy and phonophoresis, which involves using ultrasound to deliver medication through the skin. The goal is to see which method is more effective for helping patients manage their pain and improve their quality of life.
To participate in this study, you need to be between the ages of 20 and 45 and have chronic pain on one side of your lower back that is caused by a herniated disc, confirmed by an MRI. The study is not currently recruiting participants, so you would need to wait until it begins. If you have other medical conditions or previous surgeries that affect your spine, you may not be eligible to join. Participants will likely undergo both treatment methods and share their experiences, helping researchers understand which treatment works better for managing this painful condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient age ranges from 20 -45
- • Unilateral chronic lumbosacral radiculopathy
- • Intervertebral disc herniation confirmed by MRI
- * one of the following :
- • 1. H- reflex amplitude side to side difference 0.67 in absence of latency difference.
- • 2. H- reflex amplitude side to side difference smaller than 0.5 in p of latency difference.
- • 3 - Side to side H- reflex latency difference more than 1 msec. 4- Prolonged H-reflex latency more than 30 msec.
- Exclusion Criteria:
- • Systematic disease
- • Lumbar canal stenosis
- • Pervious surgeries
- • Scoliosis
- • Kyphosis
- • Spinal fracture
- • Bilateral symptoms
- • Steroid injection
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported